Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002;19(7-9):565-73.
doi: 10.1023/B:GLYC.0000014087.41914.72.

Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses

Affiliations
Review

Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses

Gabriel A Rabinovich et al. Glycoconj J. 2002.

Abstract

Galectins are a large family of structurally related beta-galactoside-binding proteins that play a pivotal role in the control of cell differentiation, proliferation, activation and apoptosis of many different cell types including immune cells. By crosslinking specific glycoconjugates, different members of the galectin family behave as pro-inflammatory or anti-inflammatory "cytokine-like" mediators, acting at different levels of innate and adaptive immune responses. Here we will review recent advances on the role of galectins in key events of the immune and inflammatory response, such as tolerance induction, cell cycle progression, cell adhesion, chemotaxis, antigen presentation and apoptosis. In particular we will examine the influence of individual members of the galectin family in the physiology of different immune cell types involved in innate and adaptive immune responses. Moreover, we will discuss the importance of these sugar-binding proteins as therapeutic targets in Th1- and Th2-mediated immune disorders, an exciting area for future research.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11329-34 - PubMed
    1. Clin Exp Immunol. 2001 May;124(2):266-73 - PubMed
    1. J Leukoc Biol. 1996 Mar;59(3):363-70 - PubMed
    1. J Immunol. 1998 Jul 1;161(1):385-9 - PubMed
    1. Lab Invest. 2002 Feb;82(2):147-58 - PubMed

Publication types

LinkOut - more resources